Ticker Search:  Getting Started | Register | Videos | Newsletter | Partners | Login    

Basics
ADC Therapeutics SA
IPO Date: May 18, 2020
Sector: Healthcare
Industry: Biotech
Market Cap: $132.9M
Activated in VL: True
Average Daily Range
Avg Daily Range: $0.41 | 3.81%
Avg Daily Range (30 D): $0.05 | 3.74%
Avg Daily Range (90 D): $0.06 | 3.50%
Institutional Daily Volume
Avg Daily Volume: .38M
Avg Daily Volume (30 D): .33M
Avg Daily Volume (90 D): .36M
Trade Size
Avg Trade Size (Sh.): 143
Avg Trade Size (Sh.) (30 D): 167
Avg Trade Size (Sh.) (90 D): 154
Institutional Trades
Total Inst.Trades: 287
Avg Inst. Trade: $1.34M
Avg Inst. Trade (30 D): $.97M
Avg Inst. Trade (90 D): $.97M
Avg Inst. Trade Volume: .16M
Avg Inst. Trades (Per Day): 1
Market Closing Trades
Avg Closing Trade: $2.39M
Avg Closing Trade (30 D): $1.32M
Avg Closing Trade (90 D): $1.32M
Avg Closing Volume: 503.58K
       
News
May 12, 2025 @ 5:00 PM
Blood Cancer Treatment Market Sees Accelerated Gro...
Source: Delveinsight
Oct 31, 2024 @ 4:57 PM
Cancer Antibody Drug Conjugates Market, Drugs Appr...
Source: Researchandmarkets.Com
Aug 6, 2024 @ 10:51 PM
ADC Therapeutics berichtet über Finanzergebniss...
Source: Adc Therapeutics
Jul 12, 2024 @ 10:40 AM
Antibody Drug Conjugates Market Insights 2018-2023...
Source: Researchandmarkets.Com
Jul 2, 2024 @ 4:27 PM
ADC Therapeutics gewährt neuen Mitarbeitern Zut...
Source: ADC Therapeutics SA
Financials
  TTM Q1 2025 Q4 2024
Basic EPS $-1.43 $-.36 $-.27
Diluted EPS $-1.43 $-.36 $-.27
Revenue $ 75.82M $ 23.03M $ 16.91M
Gross Profit $ $ $
Net Income / Loss $ -149.84M $ -38.6M $ -30.73M
Operating Income / Loss $ -125.51M $ -28.46M $ -32.44M
Cost of Revenue $ $ $
Net Cash Flow $ -39.58M $ -56.17M $ -23.41M
PE Ratio    
Splits
May 10, 2005:   7:1